Antibiotice Ia (ATB) — Cash Flow Reinvestment Rate
Antibiotice Ia (ATB) has a Cash Flow Reinvestment Rate of 0.35x as of December 2025, reinvesting RON13.33 Million (capex RON13.33 Million ) from operating cash flow of RON37.61 Million. Check Antibiotice Ia cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Antibiotice Ia Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Antibiotice Ia across 4 annual periods. Explore Antibiotice Ia cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Antibiotice Ia (2022–2025)
Year-by-year capital reinvestment analysis for Antibiotice Ia. For live market cap and broader valuation context, see Antibiotice Ia (ATB) total market value.
| Year | Reinvestment Rate | Total Reinvested (RON) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.97x | RON142.61 Million | RON72.44 Million | RON142.61 Million | ▼ -19.4% |
| 2024 | 2.44x | RON232.32 Million | RON95.15 Million | RON116.16 Million | ▲ +52.5% |
| 2023 | 1.60x | RON196.07 Million | RON122.46 Million | RON98.04 Million | ▲ +132.2% |
| 2022 | 0.69x | RON79.76 Million | RON115.66 Million | RON39.88 Million | — |